Filing Details
- Accession Number:
- 0001209191-21-036101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-26 20:25:56
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-05-26 20:25:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786391 | J. Benjamin Hindson | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-03-19 | 11,169 | $0.00 | 47,805 | No | 4 | A | Direct | |
Class A Common Stock | Disposition | 2021-05-24 | 351 | $162.66 | 47,454 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Acquisiton | 2021-03-19 | 27,922 | $0.00 | 27,922 | $177.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
27,922 | 2031-03-19 | No | 4 | A | Direct |
Footnotes
- These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- The number of shares beneficially owned following the reported transaction is as of March 19, 2021.
- These shares were sold to cover tax withholding obligations in connection with the vesting of RSUs.
- The number of shares beneficially owned following the reported transaction is as of May 24, 2021.
- This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.